BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 27561722)

  • 21. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.
    van der Veer A; Waanders E; Pieters R; Willemse ME; Van Reijmersdal SV; Russell LJ; Harrison CJ; Evans WE; van der Velden VH; Hoogerbrugge PM; Van Leeuwen F; Escherich G; Horstmann MA; Mohammadi Khankahdani L; Rizopoulos D; De Groot-Kruseman HA; Sonneveld E; Kuiper RP; Den Boer ML
    Blood; 2013 Oct; 122(15):2622-9. PubMed ID: 23974192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of High-risk Cryptic CRLF2 Rearrangements in B-Cell Acute Lymphoblastic Leukemia Utilizing an FGFR3/IGH Dual-Color Dual-Fusion DNA Probe Set.
    Robin AJ; Peterson JF; Grignon JW; Gheorghe G; Burke MJ; vanTuinen P
    J Pediatr Hematol Oncol; 2017 May; 39(4):e207-e210. PubMed ID: 27820126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
    Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia.
    Maude SL; Tasian SK; Vincent T; Hall JW; Sheen C; Roberts KG; Seif AE; Barrett DM; Chen IM; Collins JR; Mullighan CG; Hunger SP; Harvey RC; Willman CL; Fridman JS; Loh ML; Grupp SA; Teachey DT
    Blood; 2012 Oct; 120(17):3510-8. PubMed ID: 22955920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia.
    Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA
    Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.
    Sánchez R; Ribera J; Morgades M; Ayala R; Onecha E; Ruiz-Heredia Y; Juárez-Rufián A; de Nicolás R; Sánchez-Pina J; Vives S; Zamora L; Mercadal S; Coll R; Cervera M; García O; Ribera JM; Martínez-López J
    Blood Cancer J; 2020 Apr; 10(4):43. PubMed ID: 32332702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of leukemias with ETV6-ABL1 fusion.
    Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
    Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Philadelphia-like Pre-B Acute Lymphoblastic Leukemia: Experiences in Mexican Pediatric Patients.
    Martínez-Anaya D; Moreno-Lorenzana D; Reyes-León A; Juárez-Figueroa U; Dean M; Aguilar-Hernández MM; Rivera-Sánchez N; García-Islas J; Vieyra-Fuentes V; Zapata-Tarrés M; Juárez-Villegas L; Paredes-Aguilera R; Vega-Vega L; Rivera-Luna R; Juárez-Velázquez MDR; Pérez-Vera P
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.
    Messina M; Chiaretti S; Wang J; Fedullo AL; Peragine N; Gianfelici V; Piciocchi A; Brugnoletti F; Di Giacomo F; Pauselli S; Holmes AB; Puzzolo MC; Ceglie G; Apicella V; Mancini M; Te Kronnie G; Testi AM; Vitale A; Vignetti M; Guarini A; Rabadan R; Foà R
    Oncotarget; 2016 Mar; 7(12):13886-901. PubMed ID: 26883104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis.
    Csinady E; van der Velden VH; Joas R; Fischer S; de Vries JF; Beverloo HB; König M; Pötschger U; van Dongen JJ; Mann G; Haas OA; Panzer-Grümayer ER
    Leukemia; 2009 May; 23(5):870-6. PubMed ID: 19148138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
    Rasekh EO; Atef AM; Khalil M; Ebeid E; Madney Y; Hamdy N
    Clin Lab; 2021 Jan; 67(1):. PubMed ID: 33491417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
    Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
    Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic significance of
    Wang J; Sun K; Chen WM; Wang X; Li LD; Hao Y; Xu N; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Jiang Q; Qin YZ
    Leuk Lymphoma; 2023 Mar; 64(3):698-706. PubMed ID: 36642937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and
    Lee WY; Pfau RB; Choi SM; Yang J; Xiao H; Putnam EM; Ryan RJ; Bixby DL; Shao L
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.
    Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M
    Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.
    Familiades J; Bousquet M; Lafage-Pochitaloff M; Béné MC; Beldjord K; De Vos J; Dastugue N; Coyaud E; Struski S; Quelen C; Prade-Houdellier N; Dobbelstein S; Cayuela JM; Soulier J; Grardel N; Preudhomme C; Cavé H; Blanchet O; Lhéritier V; Delannoy A; Chalandon Y; Ifrah N; Pigneux A; Brousset P; Macintyre EA; Huguet F; Dombret H; Broccardo C; Delabesse E
    Leukemia; 2009 Nov; 23(11):1989-98. PubMed ID: 19587702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.
    Ensor HM; Schwab C; Russell LJ; Richards SM; Morrison H; Masic D; Jones L; Kinsey SE; Vora AJ; Mitchell CD; Harrison CJ; Moorman AV
    Blood; 2011 Feb; 117(7):2129-36. PubMed ID: 21106984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia.
    Palmi C; Vendramini E; Silvestri D; Longinotti G; Frison D; Cario G; Shochat C; Stanulla M; Rossi V; Di Meglio AM; Villa T; Giarin E; Fazio G; Leszl A; Schrappe M; Basso G; Biondi A; Izraeli S; Conter V; Valsecchi MG; Cazzaniga G; Te Kronnie G
    Leukemia; 2012 Oct; 26(10):2245-53. PubMed ID: 22484421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.